Company intelligence / Profile preview

German Accelerator Life Sciences

Cambridge, Massachusetts, United States

Ownership: Private
Employees: ~273
Development stage: Other

Overview

German Accelerator Life Sciences (GALS) is a non-profit organization, funded by the German Federal Ministry for Economic Affairs and Climate Action (BMWK). It operates as an accelerator and incubator, supporting German life science startups (diagnostics, digital health, medical devices, therapeutics, platform technologies) with market entry strategies, mentorship, and networking, primarily focusing on the U.S. and Asia markets. It offers free, equity-free programs, and its alumni have collectively raised over $2.5 billion in funding.

Industry: Investors

Partnerships

German Federal Ministry for Economic Affairs and Climate Action (BMWK)

Beyond the preview

Go deeper on German Accelerator Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on German Accelerator Life Sciences.

Explore the full profile